Author: digi

Assigning Shelf Life to Multi-Strength and Multi-Pack Products

Assigning the correct shelf life to pharmaceutical products is challenging enough—but when your drug product comes in multiple strengths or packaging configurations, the complexity increases significantly. In such cases, shelf life cannot be assumed to be identical across formats without scientific justification and stability data. This tutorial walks you through how to determine and document…

Shelf Life and Expiry, Shelf Life vs. Expiration Date: Key Differences

Conduct Container Orientation Studies to Address Leakage and Migration Risks

Understanding the Tip: What are container orientation studies and why they matter: Container orientation studies involve storing pharmaceutical products in different physical positions—upright, inverted, or horizontal—to assess packaging integrity and leakage or migration risk during stability testing. These studies simulate worst-case scenarios that may occur during storage, shipment, or use. They are especially critical for…

Stability Study Tips

Protocol Considerations for Pediatric vs. Adult Formulations

Stability testing for pharmaceutical products is already a complex task, but when formulations are tailored to different age groups — especially pediatric vs. adult patients — the design of stability protocols demands heightened precision. Pediatric drug formulations often involve unique dosage forms, excipients, and delivery systems that differ substantially from adult counterparts. These differences directly…

Protocols and Reports, Stability Study Protocols for Different Drug Types

How to Design a Bracketing and Matrixing Plan Under ICH Guidelines

Pharmaceutical stability studies can be resource-intensive and time-consuming. However, when supported by scientific justification, ICH guidelines offer flexibility through the use of bracketing and matrixing strategies. ICH Q1D provides the framework for implementing these reduced designs in new drug development. This guide outlines how to construct a bracketing and matrixing plan step by step to…

ICH Stability Guidelines (Q1A–Q1E, Q8, Q9, etc.), Regulatory Guidelines

Best Practices in QbD Application for Long-Term Stability Studies

Incorporating Quality by Design (QbD) into long-term stability studies transforms stability testing from a reactive exercise to a proactive, science-based approach. This article explores best practices for implementing QbD in long-term stability studies across the product lifecycle, using a risk-based and data-driven framework aligned with ICH Q8 guidelines. 📘 Why Apply QbD to Long-Term Stability…

Pharmaceutical Quality and Practices, Quality by Design (QbD) in Stability Testing

SOP for Implementing Stability Testing for Cell Therapy Products under ICH Q5A

SOP for Implementing Stability Testing for Cell Therapy Products under ICH Q5A Guidelines for Stability Testing of Cell Therapy Products as per ICH Q5A 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for conducting stability testing for cell therapy products in accordance with the ICH Q5A guidelines. This SOP…

Stability Studies SOP

ICH and WHO Interpretations of Expiry Terminology Explained

In the global pharmaceutical industry, the terms “shelf life”, “expiry date”, and “retest date” carry significant regulatory meaning. Misinterpreting or misapplying these terms can lead to non-compliance, labeling deviations, and product recalls. This tutorial unpacks how two major international regulatory bodies—ICH and WHO—define and use expiry-related terminology, and how pharma professionals can ensure consistency across…

Shelf Life and Expiry, Shelf Life vs. Expiration Date: Key Differences

Case Study: Protocol Design for a Temperature-Sensitive Biologic

Temperature-sensitive biologics present unique challenges during stability testing and protocol design. This case study explores the comprehensive planning and execution of a stability study for a recombinant monoclonal antibody (mAb) intended for subcutaneous injection. The molecule in question demonstrated a narrow temperature tolerance range, significant sensitivity to agitation, and a high aggregation risk. These properties…

Protocols and Reports, Stability Study Protocols for Different Drug Types

Troubleshooting Deviations Under ICH Stability Protocols

Stability testing forms a core component of product shelf life determination, and any deviation during the process—be it an Out-of-Trend (OOT) or Out-of-Specification (OOS) result—can have serious regulatory and business consequences. ICH guidelines such as Q1A(R2), Q1E, and Q5C provide principles, but the actual troubleshooting requires a methodical, documented approach. In this guide, we’ll walk…

ICH Stability Guidelines (Q1A–Q1E, Q8, Q9, etc.), Regulatory Guidelines

Case Study: Stability Optimization Through QbD

Incorporating Quality by Design (QbD) principles into stability testing isn’t just theoretical — it delivers measurable improvements in real-world pharma development. This case study details how a global pharmaceutical company applied QbD to address stability failures in a solid oral dosage form, leading to a longer shelf life and regulatory success. 📌 Background: A Persistent…

Pharmaceutical Quality and Practices, Quality by Design (QbD) in Stability Testing